GURUFOCUS.COM » STOCK LIST » USA » NYSE » Nuvation Bio Inc (NYSE:NUVB) » Definitions » 6-1 Month Momentum %
Switch to:

Nuvation Bio (NYSE:NUVB) 6-1 Month Momentum %

: -33.33% (As of Today)
View and export this data going back to 2021. Start your Free Trial

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2022-12-02), Nuvation Bio's 6-1 Month Momentum % is -33.33%.

The industry rank for Nuvation Bio's 6-1 Month Momentum % or its related term are showing as below:

NUVB's 6-1 Month Momentum % is ranked worse than
73.95% of 1555 companies
in the Biotechnology industry
Industry Median: -11.48 vs NUVB: -33.33

Nuvation Bio (NYSE:NUVB) 6-1 Month Momentum % Competitive Comparison

For the Biotechnology subindustry, Nuvation Bio's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Nuvation Bio (NYSE:NUVB) 6-1 Month Momentum % Distribution

For the Biotechnology industry and Healthcare sector, Nuvation Bio's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's 6-1 Month Momentum % falls into.



Nuvation Bio  (NYSE:NUVB) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Nuvation Bio 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (NYSE:NUVB) Business Description

Nuvation Bio logo
Traded in Other Exchanges
Address
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
Executives
Omega Fund Iv Gp, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Omega Fund V Gp Manager, Ltd. 10 percent owner 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Omega Fund V, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Omega Fund V Gp, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Hanley David C. officer: Chief Technical Operations C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Ecor1 Capital Fund, L.p. 10 percent owner 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Hattersley Gary officer: Chief Scientific Officer C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Markel Stacy officer: SVP, Human Resources RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Paster Anne-mari 10 percent owner C/O OMEGA FUND MANAGEMENT, LLC 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Nessi Claudio 10 percent owner C/O NEOMED 7 PLACE DU MOLARD 1204 GENEVA V8 1204
Fox Jennifer A. officer: Chief Financial Officer C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Ecor1 Venture Opportunity Fund, Lp 10 percent owner 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Ecor1 Panacea Holdings, Llc 10 percent owner 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Biotech Opportunity Gp, Llc 10 percent owner 1370 TRANCAS STREET, SUITE 176 NAPA CA 94558
Templeman Thomas officer: SVP, Pharmaceutical Ops C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership